FDA Clears ENeura’s STMS Device To Treat Migraines In Children 12 And Older
Feb 28, 2019 @ 16:51

With this FDA clearance, the sTMS is now the only migraine product in the United States indicated both for the acute and prophylactic treatment of migraine headache in adults and children (12 years of age and older).  More than four million children, 12 years and age and older suffer from migraine headache in the US and more than 36 million people in the US suffer from migraine headache.

Sourced through Scoop.it from: www.mpo-mag.com

Leave a Reply